Source: Junction Point News Client
Junction Point News "Thank you doctor! Thank you Director Shao's team for performing the operation on me, thank you Provincial People's Hospital for giving me the opportunity to be born again, thank you!" August 31, 34-year-old Mr. Liu walked out of the Cardiovascular Surgery Ward of Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University) and was going home.
On July 1, Mr. Liu successfully received the first artificial heart in Jiangsu Province at Jiangsu Provincial People's Hospital . It is also the first domestic artificial heart implantation of "implantable magnetic levitation ventricular assist device". . There is a "heart" controller in the strap around his waist, which is connected to the body through a wire and tube, and there are two batteries on both sides. This is Mr. Liu's "new heart". The Secretary of the Party Committee of Jiangsu Provincial People's Hospital Tang Jinhai said that this technology brings hope of rebirth to many heart failure patients who need heart transplantation .
was only 34 years old. He was diagnosed with end-stage heart failure.
The patient, Mr. Liu, has often had chest tightness and wheezing after exercise since the age of 29. He also has swelling in his legs. In severe cases, he can’t even lie down to sleep. Snoring will also cause apnea. Family members say that Mr. Liu has been in the hospital many times in five years, and the swelling will disappear every time he stays for about ten days, and he is no different from ordinary people.
The several illnesses in March of this year made him realize that his body was overloaded, and his chest tightness and asthma symptoms were so severe that he could not even take care of himself. To seek further treatment, Mr. Liu came to Jiangsu Provincial People’s Hospital for treatment. After receiving the consultation, Chief Physician Zou Jiangang from the Department of Cardiovascular Internal Medicine diagnosed him as dilated cardiomyopathy, grade 4 heart function, belonging to end-stage heart failure, and single Good results can no longer be achieved with drug treatment. So I contacted Professor Shao Yongfeng, Director of Cardiovascular Surgery of the hospital, for consultation,Hope to be treated by heart transplantation. "At that time, Director Shao was still wearing a surgical gown when he rushed to my clinic. He was surprised at first sight when he saw me. He didn't expect me to be so big." Mr. Liu recalled. It is understood that after a series of detailed examinations, it was determined that Mr. Liu’s condition met the heart transplantation indication. However, because Mr. Liu weighed 112 kg and was in serious condition, finding a suitable donor in time became a major problem. "One is the shortage of donors, and the other is that the important criterion for the use of donor hearts for heart transplantation is that the weight difference between the recipient and the donor is less than 20%. For Mr. Liu, it is necessary to find at least 90 kg of donors as soon as possible. The heart, otherwise it is equivalent to installing the car's engine on the truck, and it will not achieve the expected effect." Professor Shao Yongfeng combined with the patient's condition, the United Hospital's multidisciplinary experts consulted and discussed, and finally decided to adopt another treatment method-implantation in the ventricle. assisting equipments.
The first case in Jiangsu where a domestic artificial heart allowed him to "regain his heart"
After staying in the cardio-macrovascular surgery for a period of time, Mr. Liu's symptoms improved slightly, but he still could not get out of bed at will, ECG Monitoring also detected that Mr. Liu had paroxysmal arrhythmia, and he urgently needed a beating heart. "How about you have to give it a try, he is still so young, we don't want our children to walk in front of parents", Mr. Liu's father introduced, at this time, the implantable magnetic fluid suspension ventricular assist device-artificial heart was given to them A silver lining.
It is understood that ventricular assist devices are an internationally recognized treatment for heart failure. In developed countries such as Europe, America and Japan, the price of a single product is about US$100,000, and it has been included in medical insurance. "The demand for ventricular assist devices is also very large in China. Taking into account economic and social factors, even if only one in 1,000 people with heart failure in China can use this product each year, the annual demand exceeds 10,000 sets." According to Shao Yongfeng, the implantable magnetic fluid suspension ventricular assist device used in this operation is the first original artificial heart with independent intellectual property rights in China. After being implanted in the human body, it can effectively provide support and assistance to patients with heart failure. Implantation is equivalent to installing an active heart'pump' for the patient's own heart, which assists or replaces the pumping function of the real heart through the working principle of the'pump'.This allows one's own heart to'rest' and at the same time guarantees the purpose of perfusion of important organs such as the brain, kidney, and liver. Shao Yongfeng said.
In order to ensure foolproof, the hospital’s party committee secretary Tang Jinhai, dean Zhao Jun, deputy dean Liu Yun and other research deployments, all departments are fully coordinated, the whole hospital cooperates with all departments, and cardiovascular surgery Complete patient preoperative preparation, new technology ethical review and admission permit work in a very short time, and at the same time cooperate with cardiovascular medicine, operating room, anesthesia and perioperative medicine, intensive care unit, extracorporeal circulation, blood transfusion, The clinical laboratory and other related brother departments formed a team of experts and held several meetings to discuss preoperative preparations, surgical procedures and postoperative treatments, and worked out a detailed surgical plan. At 16:00 on June 30, the expert team held the last preoperative meeting Case discussion and careful deployment of each link to make full preparations for the operation. At 10 am on July 1st, the operation officially began. Professor Shao Yongfeng’s team successfully implanted an artificial heart for Mr. Liu. The operation process went smoothly and the postoperative vital signs Stable.
Pure domestic artificial heart brings hope to patients with heart failure
It is understood that heart failure is the terminal stage of the development of heart disease, and for most patients with heart failure, it is a life-saving treatment plan It is the implementation of heart transplantation and artificial heart implantation. According to statistics, there are currently at least 1 million heart failure patients in China, while only about 500 heart transplants are performed every year. "Due to the scarcity of donors and the difficulty of operation. Many patients with heart failure died unfortunately while waiting for the donor for a long time. The popularization and promotion of artificial heart implant surgery will bring new hope to these patients. After investigation, the original heart function of some patients may be restored after the operation. At this time, the artificial heart can be considered to be removed. "Shao Yongfeng said. "After I leave the hospital, I have to adapt to this'new friend' and learn how to get along with it day and night and stay inseparable." Mr. Liu said that the small box in the backpack in front of him is outside his "heart". Controller, this controller is also equipped with two batteries, each battery can be used for about 6 hours. There is also a cable connected to the body of the controller,The other end of the cable is a blood pump installed under the heart to replace or assist the heart's pumping function. The weight is only 180 grams. "In the future, as long as I ensure that the battery is continuously charged and the cables are continuously connected, I can live like normal people." Mr. Liu said. It is understood that the implanted by the patient Mr. Liu is the first implantable magnetic fluid suspension ventricular assist device in Jiangsu Province. The device is small and has little impact on the patient’s daily life. Produced by a state-owned enterprise; the only combination of medicine and industry from beginning to end; the only domestic original and independent intellectual property rights; the only domestic research and development of a complete set of products. Xinhua Daily, Junction Point reporter Zhong Chongshan Wang Zijie Correspondent He Yutian Wan Li Li Jieyin
This article is from [Junction Point News Client], which only represents the author's views. The national party media information public platform provides information publishing and dissemination services.
ID: jrtt
.
